Charles Baum, Director at Array Biopharma, holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX), holds 58.95K shares in Poseida Therapeutics (Ticker: PSTX), holds 0.00 shares in Immunomedics (Ticker: IMMU).
What is the percentage of profitable transactions made by Charles Baum?
The percentage of profitable transactions made by Charles Baum is 63%.
What is the average return per transaction made by Charles Baum?
The average return per transaction made by Charles Baum is 33.10%.
What stocks does Charles Baum hold?
Charles Baum holds: ~ARRY, IMMU, PMVP, PSTX, ACRV, MRTX stocks.
What was Charles Baum’s latest transaction?
Charles Baum latest transaction was an Uninformative Sell of ―.
What was Charles Baum's most profitable transaction?
Charles Baum’s most profitable transaction was an Informative Buy of MRTX stock on March 30, 2020. The return on the trade was 164.40%.
What is Charles Baum's role in Array Biopharma?
Charles Baum's role in Array Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.